The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrontier Ip Regulatory News (FIPP)

Share Price Information for Frontier Ip (FIPP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 41.50
Bid: 40.00
Ask: 43.00
Change: 0.00 (0.00%)
Spread: 3.00 (7.50%)
Open: 41.50
High: 41.50
Low: 41.50
Prev. Close: 41.50
FIPP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

New advisory client, Vertequip

9 Mar 2015 07:00

RNS Number : 7807G
Frontier IP Group plc
09 March 2015
 



 

 

AIM: FIPP

Frontier IP Group plc

("Frontier IP" or "the Company")

 

New Advisory Client - Vertequip

Frontier IP, which specialises in the commercialisation of intellectual property, is pleased to announce that it has been engaged to provide advisory and business development services to VERTEQUIP - Equipamentos e trabalhos verticais, LDA ("Vertequip").

Vertequip, a Portuguese company, was formed to develop and exploit a new technology, STEP (http://site.vertequip.com/products), which allows the service and maintenance of high vertical structures to be performed in a safer, faster and more cost-effective way. Vertequip is targeting the renewable energy, construction, offshore oil & gas and relevant industrial markets. Current customers include utilities and energy companies, who respectively use Vertequip solutions in wind turbines and dams, and for the maintenance of offshore oil rigs.

Frontier IP will assist Vertequip in further exploiting the commercial potential of its technology and to accelerate the expansion of its sales into new and existing markets.

Neil Crabb, Chief Executive of Frontier IP, said,

"This collaboration with Vertequip represents an exciting opportunity for Frontier IP in the energy market. Our strategy to focus on energy as one of our key sectors is progressing well, as we expand our resource and build connections to a network of market players such as EDP and Iberdrola, two major utilities. We look forward to working with Vertequip to maximise the potential of its innovative technology and product range."

Pedro Goncalves, Chief Operating Officer of Vertequip, said,

"We are delighted to enter into this agreement and get the support of Frontier IP on the commercialisation of our innovative products."

 

Enquiries

 

Frontier IP Group Plc

0131 240 1251

 

Neil Crabb, Chief Executive

 

Company website: www.frontierip.co.uk

 

 

Cantor Fitzgerald Europe

(Nominated Adviser and Joint Broker)

020 7894 7000

 

Mark Percy / Catherine Leftley, Corporate Finance

 

David Banks, Corporate Broking

 

 

Peterhouse Corporate Finance Limited (Joint Broker)

020 7469 0935

 

Lucy Williams

 

 

KTZ Communications

020 3178 6378

 

Katie Tzouliadis / Deborah Walter

 

 

Notes to Editor:

 

Frontier IP Group plc

Frontier IP specialises in assisting universities, research institutions and companies in the commercialisation and exploitation of their Intellectual Property.

 www.frontierip.co.uk.

 

Vertequip - Equipamentos e trabalhos verticais, LDA

Vertequip specialises in the production of service and maintenance equipment for high vertical structures, including oil rigs, wind turbines, mines and construction sites. Its principal product, STEP, is designed to increase safety and enhance productivity when working at considerable heights.

 

Vertiquip is based in Portugal, with distributors selling its products across Europe, Africa, the Middle East and South America.

http://site.vertequip.com/products

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAKMGGFMVKGKZM
Date   Source Headline
7th May 202410:15 amRNSTVG to collaborate with The Pirbright Institute
2nd May 20247:00 amRNSFrontier IP announces stake in DiaGen
17th Apr 20241:59 pmRNSHolding(s) in Company
12th Apr 20247:00 amRNSAppointment of Chief Financial Officer
2nd Apr 202412:44 pmRNSHolding(s) in Company
14th Mar 20247:00 amRNSUnaudited Half Year Results
4th Mar 20241:40 pmRNSHolding(s) in Company
29th Feb 20243:12 pmRNSSale of shares in Exscientia
30th Jan 202411:45 amRNSHolding(s) in Company
22nd Jan 20247:00 amRNSOctopus invest in Alusid as part of equity funding
29th Dec 202312:00 pmRNSTotal Voting Rights
19th Dec 20234:46 pmRNSHolding(s) in Company
15th Dec 20236:12 pmRNSReplacement - Result of AGM and Directorate Change
15th Dec 20232:07 pmRNSResult of AGM and Directorate Change
13th Dec 20237:00 amRNSPortfolio news - The Vaccine Group
11th Dec 20237:00 amRNSHolding(s) in Company
30th Nov 20235:00 pmRNSTotal Voting Rights
30th Nov 20237:00 amRNSExercise of Options & Director/PDMR Shareholdings
28th Nov 20237:00 amRNSBoard Change
21st Nov 20237:00 amRNSPosting of Annual Report and Notice of AGM
9th Nov 20235:27 pmRNSHolding(s) in Company
3rd Nov 20237:05 amRNSGrant of options
1st Nov 20235:48 pmRNSExercise of Options & PDMR Shareholdings & TVR
31st Oct 20237:01 amRNSBoard changes
31st Oct 20237:00 amRNSFinal results for the year ended 30 June 2023
23rd Oct 20237:00 amRNSNew portfolio company Deakin Bio-Hybrid Materials
12th Oct 20232:05 pmRNSHolding(s) in Company
21st Sep 20237:00 amRNSExscientia announces collaboration with Merck
14th Sep 20235:21 pmRNSHolding(s) in Company
14th Sep 20237:00 amRNSExercise of Options & Total Voting Rights
11th Sep 20237:00 amRNSPortfolio news – Pulsiv appoints Chairman and CPO
8th Sep 20237:00 amRNSExercise of Options & Total Voting Rights
10th Aug 20238:45 amRNSPortfolio news – Fieldwork Robotics
24th Jul 20237:00 amRNSPortfolio news – CamGraPhIC loan facility
20th Jul 20235:18 pmRNSHolding(s) in Company
1st Jun 20237:00 amRNSSale of shares in Exscientia
26th May 20236:06 pmRNSHolding(s) in Company
9th May 20237:00 amRNSTopps Tiles launches first Alusid made tile range
21st Apr 20234:00 pmRNSDirectorate Change
20th Apr 20235:26 pmRNSHolding(s) in Company
27th Mar 20235:17 pmRNSHolding(s) in Company
17th Mar 20232:46 pmRNSGrant of options
15th Mar 20237:00 amRNSBoard changes
15th Mar 20237:00 amRNSUnaudited Half Year Results
30th Jan 20237:00 amRNSAlusid in collaboration with Imerys
9th Jan 20237:00 amRNSCelerum appoints David Gladding as CEO
9th Dec 20224:08 pmRNSResult of AGM
7th Dec 20221:25 pmEQSThe Vaccine Group completes two deadly disease vaccination projects
6th Dec 20227:00 amRNSFrontier IP to host Portfolio Demo Day
5th Dec 20227:00 amRNSThe Vaccine Group completes Lassa fever project

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.